Skip to main content
Caplight Logo









BforCure

BforCure

Private
MontreuilHealthcare & Life Scienceshttps://www.bforcure.com/

Last Round

Grant

Mar 1, 2024

Total Funding Raised

$17.21M

Company Overview

BforCure is a biotechnology company that develops and commercializes advanced molecular analysis technologies and biosensing equipment for rapid microbiota characterization.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Medical Devices, Environmental Monitoring, Defense Tech

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

molecular diagnosticspoint-of-need testingmicrobiota analysisqPCRdigital PCRlab-on-a-chipmicrofluidicsrapid diagnosticsbiodefensewater quality monitoringfood safety testingdiagnostic hardwarePOCTmultiplex PCRbioinformatics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BforCure Comparables

Compare BforCure with similar companies based on industry and business-model similarity.

BforCure comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GoDx, Inc.
83%
Alveo Technologies
81%
Biomeme
79%

BforCure Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 1, 2024
GrantMar 21, 2022
Series AMar 21, 2022
SeedOct 13, 2021
GrantMay 28, 2021
Grant
Apr 7, 2020

Key People

Founding team and executive leadership

Christophe PANNETIER

Chief Scientific Officer Co-founder

Founding Team

Jérôme Iglesias

Co-founder & Managing Director œnobiote, Chief Revenue Officer

Founding Team

Maël Le Berre

CEO, CTO

Executive Team

BforCure Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 11, 2024

    Monthly visitors increased 279% MoM.

  • Mar 1, 2024

    Secured $2.67M in grant funding from the European Innovation Council.

BforCure Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BforCure Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BforCure's valuation, stock price, and market status.

Firmographic Details

HeadquartersMontreuil
Employee Range28
Year Founded2018
Last FundingMar 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?